关于可逆共价抑制剂的发现和开发的最新情况
Faridoon1, Raymond Ng2, Guiping Zhang1
1Genhouse Bio, No.1 Xinze Road, Suzhou Industrial Park, Suzhou, Jiangsu Province 215123 PR China.
概括
与不可逆转的抑制剂相比,可逆共价药物通过最大限度地减少非向效应,提供了更好的安全性. 本综述探讨了用于设计更安全,选择性共价药物的电友核弹头.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 化学生物学 化学生物学
背景情况:
- 不可逆转的共价药物提供治疗优势,如长时间的作用,但存在毒性和免疫性风险.
- 通过不可逆转的共价药物永久修改非标蛋白质,可能导致特异性毒性和形形成.
- 将可逆性引入到共价药物设计中,通过形成短暂的添加物来减轻这些风险.
研究的目的:
- 系统地审查用于可逆共价药物开发的电友核弹头.
- 为提高药物选择性和安全性提供对弹头设计的结构性见解.
主要方法:
- 在可逆共价药物设计中对电友弹头的系统文献综述.
- 分析影响目标上的选择性和目标之外的相互作用的结构特征.
主要成果:
- 识别和分类各种适用于可逆共价抑制的电友核弹头.
- 讨论结构-活动关系,以实现所需的可逆性和选择性.
结论:
- 可逆共价药物是一种有希望的策略,可以提高药物安全性.
- 了解电友核弹头化学对于设计具有改善治疗指数的共价药物至关重要.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
06:34Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
Published on: June 20, 2014
13.9K
相关概念视频
Enzyme Inhibition
78.8K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.8K
Drug-Receptor Bonds
3.0K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
3.0K
Covalent Bonds
146.8K
Overview
146.8K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Limitations of Friedel–Crafts Reactions
5.5K
Several restrictions limit the use of Friedel–Crafts reactions. First, the halogen in the alkyl halide must be attached to an sp3-hybridized carbon for the Friedel–Crafts reactions to occur. Vinyl or aryl halides do not react since the carbocations formed are unstable under the reaction conditions. Second, Friedel–Crafts alkylation is susceptible to carbocation rearrangement, and the major products obtained have a rearranged carbon skeleton. In contrast, the acylium ion is...
5.5K
Introduction to Enzymes
18.8K
The use of enzymes by humans dates to 7000 BCE. Humans first used enzymes to ferment sugars and produce alcohol without knowing that this was an enzyme-catalyzed reaction. Wilhelm Kuhne coined the term 'enzyme' in 1877 from the Greek words ‘en’ meaning ‘in’ or ‘within’ and ‘zyme’ meaning ‘yeast.’
Most enzymes are proteins that speed up biochemical reactions without being consumed. Enzymes contain one or more active sites that...
Most enzymes are proteins that speed up biochemical reactions without being consumed. Enzymes contain one or more active sites that...
18.8K
